These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 31551498)
21. miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease. Han SA; Jhun BW; Kim SY; Moon SM; Yang B; Kwon OJ; Daley CL; Shin SJ; Koh WJ Sci Rep; 2020 Feb; 10(1):3178. PubMed ID: 32081976 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian. Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467 [TBL] [Abstract][Full Text] [Related]
23. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease. Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008 [TBL] [Abstract][Full Text] [Related]
24. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis. Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644 [TBL] [Abstract][Full Text] [Related]
25. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Gui Y; Liu H; Zhang L; Lv W; Hu X Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684 [TBL] [Abstract][Full Text] [Related]
26. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease. Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254 [TBL] [Abstract][Full Text] [Related]
27. Peripheral blood mononuclear cell microRNA profiles in syphilitic patients with serofast status. Jia X; Wang Z; Liu X; Zheng H; Li J Mol Biol Rep; 2020 May; 47(5):3407-3421. PubMed ID: 32333247 [TBL] [Abstract][Full Text] [Related]
28. Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples. Chen L; Yang J; Lü J; Cao S; Zhao Q; Yu Z Brain Behav; 2018 Apr; 8(4):e00941. PubMed ID: 29670823 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles. Cao XY; Lu JM; Zhao ZQ; Li MC; Lu T; An XS; Xue LJ Neurosci Lett; 2017 Mar; 644():94-99. PubMed ID: 28223160 [TBL] [Abstract][Full Text] [Related]
30. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease. Alieva AKh; Filatova EV; Karabanov AV; Illarioshkin SN; Limborska SA; Shadrina MI; Slominsky PA Parkinsonism Relat Disord; 2015 Jan; 21(1):72-4. PubMed ID: 25465742 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression profiling of peripheral blood mononuclear cells associated with syphilis. Huang T; Zhang J; Ke W; Zhang X; Chen W; Yang J; Liao Y; Liang F; Mei S; Li M; Luo Z; Zhang Q; Yang B; Zheng H BMC Infect Dis; 2020 Feb; 20(1):165. PubMed ID: 32087699 [TBL] [Abstract][Full Text] [Related]
32. Role and Dysregulation of miRNA in Patients with Parkinson's Disease. Salemi M; Marchese G; Lanza G; Cosentino FII; Salluzzo MG; Schillaci FA; Ventola GM; Cordella A; Ravo M; Ferri R Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614153 [TBL] [Abstract][Full Text] [Related]
33. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease. Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415 [TBL] [Abstract][Full Text] [Related]
34. Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease. Yousefi M; Peymani M; Ghaedi K; Irani S; Etemadifar M Sci Rep; 2022 Feb; 12(1):2569. PubMed ID: 35173238 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus. Takahashi P; Xavier DJ; Evangelista AF; Manoel-Caetano FS; Macedo C; Collares CV; Foss-Freitas MC; Foss MC; Rassi DM; Donadi EA; Passos GA; Sakamoto-Hojo ET Gene; 2014 Apr; 539(2):213-23. PubMed ID: 24530307 [TBL] [Abstract][Full Text] [Related]
36. Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease. Martins M; Rosa A; Guedes LC; Fonseca BV; Gotovac K; Violante S; Mestre T; Coelho M; Rosa MM; Martin ER; Vance JM; Outeiro TF; Wang L; Borovecki F; Ferreira JJ; Oliveira SA PLoS One; 2011; 6(10):e25443. PubMed ID: 22003392 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease. Li H; Yu L; Li M; Chen X; Tian Q; Jiang Y; Li N Mol Genet Genomic Med; 2020 Apr; 8(4):e1189. PubMed ID: 32077254 [TBL] [Abstract][Full Text] [Related]
38. Multi-omic landscaping of human midbrains identifies disease-relevant molecular targets and pathways in advanced-stage Parkinson's disease. Caldi Gomes L; Galhoz A; Jain G; Roser AE; Maass F; Carboni E; Barski E; Lenz C; Lohmann K; Klein C; Bähr M; Fischer A; Menden MP; Lingor P Clin Transl Med; 2022 Jan; 12(1):e692. PubMed ID: 35090094 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of gut miRNAs in idiopathic Parkinson's disease. Kurz A; Kumar R; Northoff BH; Wenk C; Schirra J; Donakonda S; Höglinger GU; Schwarz J; Rozanski V; Hübner R; Bötzel K; Holdt LM; Koeglsperger T Parkinsonism Relat Disord; 2021 Jul; 88():46-50. PubMed ID: 34118643 [TBL] [Abstract][Full Text] [Related]
40. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]